Abbott Laboratories
Abbott Laboratories is American global health care and medical device products company. Founded in 1888. Led by CEO Miles D. White. Approximately 73,000 employees. (Wikidata)
Abbott Laboratories's strongest tracked position is the Interventional Cardiology Market at an estimated 21.0% share in a market growing at 6.3% CAGR.
Meridian Consensus tracks Abbott Laboratories in 1 market across 1 industry (Healthcare). Estimated in-market revenue is $3.9B, the sum of share × market size across appearances — a modeled figure, not reported company revenue.
Filed financials · SEC 10-K · FY2025
EDGAR · CIK 1800Exchange-filed figures from SEC XBRL companyfacts (ABBOTT LABORATORIES). The modeled in-market estimates below cover only the markets Meridian tracks and will not sum to filed revenue.
Share and revenue figures are Meridian model estimates reconciled through the publish-gate validator, not audited financials. Methodology
Market positions
| Market | CAGR | Share |
|---|---|---|
| Interventional Cardiology Market | 6.3% | 21.0% |
Meridian Dossier
Need diligence-grade depth on Abbott Laboratories?
Commission a source-cited diligence dossier on Abbott Laboratories: identity, filed financials, IP, litigation, and government exposure. Free preview first, from $299.
Abbott Laboratories: frequently asked
Meridian Consensus tracks Abbott Laboratories in 1 market: Interventional Cardiology Market ($18.5B), spanning Healthcare.
Abbott Laboratories's strongest tracked position is the Interventional Cardiology Market, a $18.5B market growing at 6.3% CAGR, where it holds an estimated 21.0% share as of May 2026.
Across Meridian-tracked markets, Abbott Laboratories's closest peers are Boston Scientific, Medtronic plc, Edwards Lifesciences, Terumo Corporation, B. Braun Melsungen, with the largest overlap in the Interventional Cardiology Market. Peer mapping is based on co-appearance in the same tracked markets.
No. Share and revenue figures on this page are model estimates produced by Meridian's research pipeline and committee-reviewed before publication; they are not audited or exchange-filed financials. Market-level sizings are reconciled against external sources during the publish gate.
Adjacent markets in Healthcare
Tracked markets in the same industry where Abbott Laboratories is not among the named operators. Each carries Porter Five Forces, SWOT, country analysis, and a full competitor table.
Operators that compete with Abbott Laboratories
Abbott Laboratories's closest peers across Meridian-tracked markets are Boston Scientific, Medtronic plc, Edwards Lifesciences, among others, ordered by how many tracked markets they share with the operator.
- 1 sharedBoston ScientificTop overlap · Interventional Cardiology
- 1 sharedMedtronic plcTop overlap · Interventional Cardiology
- 1 sharedEdwards LifesciencesTop overlap · Interventional Cardiology
- 1 sharedTerumo CorporationTop overlap · Interventional Cardiology
- 1 sharedB. Braun MelsungenTop overlap · Interventional Cardiology
- 1 sharedCook MedicalTop overlap · Interventional Cardiology
- 1 sharedTeleflexTop overlap · Interventional Cardiology
- 1 sharedCardinal HealthTop overlap · Interventional Cardiology
- 1 sharedMicroPort ScientificTop overlap · Interventional Cardiology
- 1 sharedBiotronikTop overlap · Interventional Cardiology
Or browse the full A–Z operator directory for any company in the catalogue.
Meridian Consensus Digest
Free · WeeklyNot ready to commission a full report? Get our weekly briefing instead: new market sizings, thesis revisions, and reconciliation updates. Signed by the research team. No sales emails.